Showing results (21-30 of 135) with videos related to
Sort By:
Pageof 14
Cancer Research|December 1, 1990
Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cellsM R Horsman, D J Chaplin, J OvergaardAnticancer Research|September 1, 1993
Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumourC S Parkins, J Denekamp, D J ChaplinRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The use of blood flow modifiers to improve the treatment response of solid tumorsM R Horsman, D J Chaplin, J OvergaardInternational Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugsD J Chaplin, B Acker, P L OliveThe British Journal of Cancer. Supplement|July 1, 1996
Changes in coagulation and permeability properties of human endothelial cells in vitro induced by TNF-alpha or 5,6 MeXAAM E Watts, S Arnold, D J ChaplinAnticancer Research|May 5, 1999
Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphateD J Chaplin, G R Pettit, S A HillBritish Journal of Cancer|August 1, 1993
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeD J Chaplin, M R Horsman, D W SiemannThe British Journal of Radiology|February 1, 1997
Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent mannerC E Peters, D J Chaplin, D G HirstCancer Investigation|September 6, 2017
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat CancerD W Siemann, D J Chaplin, M R HorsmanBiomedica Biochimica Acta|January 1, 1989
Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapyD J Chaplin, B D Acker, M R HorsmanPageof 14